Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05963685
Other study ID # MT-ALARM
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 16, 2022
Est. completion date March 15, 2024

Study information

Verified date July 2023
Source Munich Municipal Hospital
Contact Hanni Wiestler, MD
Phone +49 89 6210 5895
Email hanni.wiestler@muenchen-klinik.de
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The aim of this study is to evaluate the impact of a standardized alarming system on treatment times and workflow in stroke patients with interhospital transfer for mechanical thrombectomy (MT). The main questions it aims to answer are: - Is the implementation of a standardized alarming system associated with shorter transfer and treatment times? - Is the implementation of a standardized alarming system associated with a better adherence on existing standard operating procedures for interhospital transfer? We will analyze data from our existing thrombectomy registry comparing time periods before and after introduction of the MT alarming system.


Recruitment information / eligibility

Status Recruiting
Enrollment 280
Est. completion date March 15, 2024
Est. primary completion date March 15, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age >= 18 years - diagnosis of acute ischemic stroke - indication for mechanical thrombectomy - admission to one of 7 participating primary stroke centers within in the catchment area of the referral center Exclusion Criteria: - unclear indication for mechanical thrombectomy (patients admitted for perfusion imaging before decision for or against a MT)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
standardized MT alarming system
Standardized alarming system via telephone loop in the primary thrombectomy centre triggered immediately after decision to mechanical thrombectomy in stroke patients admitted in primary stroke centers

Locations

Country Name City State
Germany Munich Municipal Hospital Munich Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Munich Municipal Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary decision-to-groin time time from decision for MT (while patient still in the primary stroke center) to groin puncture (start of mechanical thrombectomy procedure in the primary thrombectomy center) 24 hours
Secondary decision-to-departure time time from decision for MT to departure of the patient from primary stroke center (to the primary thrombectomy center) 24 hours
Secondary decision-to-arrival time time from decision for MT to arrival of the patient at the primary thrombectomy center 24 hours
Secondary arrival-to-groin time time from arrival of the patient at the primary thrombectomy center to groin puncture (start of mechanical thrombectomy procedure) 24 hours
Secondary rate of refusal of transfer requests due to lack of capacity rate of patients that had to be transferred to a secondary thrombectomy center instead of the primary thrombectomy centre due to lack of capacity in the referral clinic 24 hours
Secondary decision-to-transfer request time Time from decision for MT to request of emergency medical service for interhospital transfer 24 hours
Secondary Periprocedural complications rate of periprocedural complications during MT 24 hours
Secondary Successful outcome of MT (mTICI > 2b) rate of successfully performed MT (mTICI > 2b) of all patients with attempted MT 24 hours
Secondary groin-to-recanalization time Time from groin puncture to successful recanalization 24 hours
Secondary Adverse events within 7 days Adverse events within the first 7 days after transfer to referral center 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT06113848 - Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy Phase 3
Completed NCT04069546 - The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency N/A
Active, not recruiting NCT05700097 - Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Phase 2
Recruiting NCT06058130 - Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis N/A
Recruiting NCT04415164 - Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Phase 4
Recruiting NCT05363397 - Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke Phase 2
Completed NCT05429658 - Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System N/A
Recruiting NCT05390580 - Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct N/A
Enrolling by invitation NCT05515393 - A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Phase 2
Active, not recruiting NCT05070260 - ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo Phase 2/Phase 3
Terminated NCT05547412 - Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
Completed NCT03366818 - New Stent Retriever, VERSI System for AIS N/A
Not yet recruiting NCT06437431 - Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy Phase 2/Phase 3
Not yet recruiting NCT06040476 - Human Umbilical Cord Blood Infusion in Patients With Acute Ischemic Stroke (AIS) Phase 2
Not yet recruiting NCT05293080 - Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE Phase 3
Completed NCT02223273 - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke) N/A
Completed NCT02586233 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Phase 1/Phase 2
Terminated NCT01694381 - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor Early Phase 1
Not yet recruiting NCT01594190 - Physical Activity Immediately After Acute Cerebral Ischemia N/A
Completed NCT01120301 - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Phase 3